Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06078865 · ClinicalTrials.gov registry record

FX Shoulder Prospective Clinical Study

A clinical trial of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, sponsored by FX Shoulder Solutions.

Recruiting
Registry status
600
Enrollment target
4
Study locations

NCT06078865 is a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders that is actively recruiting participants, run by FX Shoulder Solutions. The registered enrollment target is 600 participants, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06078865, a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, is actively recruiting participants, sponsored by FX Shoulder Solutions.

RECRUITING
Registry status
600 participants
Enrollment target
4
Study locations

Study Summary

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

Interventions

  • DEVICE FX Artificial Shoulder Prosthesis

Study Locations (4)

Arizona

  • OrthoArizona - Gilbert

Ohio

  • First Settlement Orthopedics - Marietta

Rhode Island

  • Orthopedics Rhode Island - Wakefield

Texas

  • Texas Orthopedic Specialists - Bedford

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2021-03-31
Est. Completion 2031-12-30

Sponsor

FX Shoulder Solutions

2 total trials

What the Registry Record Tells You About NCT06078865

The ClinicalTrials.gov registry entry for NCT06078865 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher). The listed sponsor is FX Shoulder Solutions, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Osteoarthritis Shoulder appearing as the primary indexed condition, and to 1 intervention - of which FX Artificial Shoulder Prosthesis is the first listed.

NCT06078865 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Ohio, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06078865 about?

NCT06078865 is a clinical study titled "FX Shoulder Prospective Clinical Study". Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

What is the current status of trial NCT06078865?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-03-31. Estimated completion is 2031-12-30.

What conditions does trial NCT06078865 study?

This clinical trial studies the following conditions: Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Fracture, Shoulder.

What interventions are being tested in trial NCT06078865?

The interventions under investigation include: FX Artificial Shoulder Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT06078865?

This trial is sponsored by FX Shoulder Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06078865 being conducted?

This trial has 4 study locations across Arizona, Ohio, Rhode Island, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis Shoulder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.